Who Owns Disc Medicine Stock?
NASDAQ: IRONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 114.11%
- Institutions (% of float)
- 123.81%
- Held by insiders
- 7.84%
- Institutional holders
- 301
- Institutions 92.2%
- Insiders 7.8%
- Public and other 0.0%
Who owns Disc Medicine stock?
Institutional investors own about 114.1% of Disc Medicine's shares, spread across 301 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 7.84% of IRON.
The largest institutional holders are FMR, LLC (12.75%), Blackrock Inc. (6.43%) and RA Capital Management, L.P. (6.38%). Together, the top 10 institutions control 55.7% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their IRON positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IRON
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 4.89M | 12.75% | -12.4% |
| Blackrock Inc. | 2.47M | 6.43% | +8.5% |
| RA Capital Management, L.P. | 2.45M | 6.38% | 0.0% |
| JPMORGAN CHASE & CO | 1.88M | 4.89% | +36.8% |
| Price (T.Rowe) Associates Inc | 1.88M | 4.88% | +21.0% |
| Wellington Management Group, LLP | 1.74M | 4.54% | +0.3% |
| State Street Corporation | 1.65M | 4.29% | -2.9% |
| Vestal Point Capital, LP | 1.55M | 4.04% | +121.4% |
| Atlas Venture Life Science Advisors, LLC | 1.51M | 3.94% | 0.0% |
| Vanguard Capital Management LLC | 1.37M | 3.57% | -0.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IRON
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 2.15M | 5.60% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.01M | 2.63% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 970.66K | 2.53% |
| iShares Trust-iShares Russell 2000 ETF | 728.52K | 1.90% |
| JPMorgan Trust II-JPMorgan Mid Cap Growth Fund | 647.79K | 1.69% |
| T. Rowe Price New Horizons Fund, Inc. | 566.76K | 1.48% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 454.77K | 1.18% |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 395.24K | 1.03% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 380.00K | 0.99% |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | 375.60K | 0.98% |
Frequently asked questions
Who is the largest shareholder of Disc Medicine?
FMR, LLC is the largest institutional shareholder of IRON, owning 12.75% of shares outstanding (4.89M shares) as of its latest 13F filing.
What percentage of Disc Medicine is owned by institutions?
Institutions own about 114.1% of IRON shares and 123.8% of the public float.
How much of Disc Medicine do insiders own?
Insiders, such as officers and directors, own about 7.84% of IRON shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.